| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.098 | 0.07 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.07 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.07 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.07 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.07 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |